⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNGX News
Tango Therapeutics, Inc.
Form 8-K
sec.gov
TNGX
Form 8-K
sec.gov
TNGX
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
globenewswire.com
TNGX
Form 8-K
sec.gov
TNGX
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TNGX
Form 8-K
sec.gov
TNGX
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
globenewswire.com
TNGX
RMD
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
globenewswire.com
ATOS
ONCY
SNSE
TNGX
OSTX
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TNGX
Form 8-K
sec.gov
TNGX